Skip to main content
Menu
US

LANCE Ultra Phospho-BTK (Tyr223) Detection Kit, 10,000 Assay Points

LANCE Ultra phospho-BTK (Tyr223) kits are designed for the detection of phosphorylated BTK in cell lysates using a simple, homogeneous LANCE Ultra assay (no wash steps). This assay is compatible with both adherent and suspension cells.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Part number: TRF4021C
Unit Size: 500 Assay Points
List price: USD 2,043.00
Your price: Login to view
USD 0.00
USD 2,043.00 /each
Part number: TRF4021M
Unit Size: 10,000 Assay Points
List price: USD 9,232.00
Your price: Login to view
USD 9,232.00
USD 9,232.00 /each

Overview

Please note control lysates are sold separately, catalog number TRF4021S.

Formats:

  • Our 500 assay point kit allows you to run 500 wells in 384-well format, using a 20 µL reaction volume.
  • Our 10,000 assay point kit allows you to run 10,000 wells in 384-well format, using a 20 µL reaction volume.

LANCE® and LANCE® (Lanthanide chelate excite) Ultra are homogeneous (no wash) TR-FRET (time-resolved fluorescence resonance energy transfer) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second antibody is labeled with an acceptor fluorophore [ULight™ dye]. Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm. Data are represented as ratiometric (665/615 nm X 10,000).

BTK is a cytoplasmic tyrosine kinase present in B-cells. It is associated with the B-cell receptor and receptors of the toll family. Upon activation, BTK will activate the Nf-kB pathway. This will induce maturation of B-cells into antibody producing cells and also increase the secretion of activating cytokines (such as IL-2). The protein is absent or non-functional in diseases such as aglobularia, but is also involved by hyperactivation in inflammation and auto-immune diseases. Also, several leukemia-like cancers have dysregulation of BTK.

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
LANCE Ultra
Detection Modality
LANCE
Molecular Modification
Phosphorylation
Product Group
Kit
Sample Volume
15 µL
Shipping Conditions
Shipped in Blue Ice
Target
BTK
Target Class
Phosphoproteins
Technology
TR-FRET
Therapeutic Area
Autoimmunity
Immuno-oncology
Neuroscience
Oncology
Unit Size
10,000 Assay Points

Resources

1-1 of 1 Resources
Product Info Icon
Product Info
LANCE and LANCE Ultra TR-FRET technology product list

LANCE™ Ultra TR-FRET is a no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence...

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
IFUs, Manuals & more
Scroll Icon